Self-Injury Treatment and Recovery in Veterans
STRIVe
A Brief Intervention to Reduce Nonsuicidal Self-Injury and Improve Functioning in Veterans
2 other identifiers
interventional
40
1 country
1
Brief Summary
Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times higher than the general population. Moreover, NSSI is associated with increased risk for violence, psychiatric distress, and marked impairment in psychosocial functioning. Even though NSSI is distinct from suicidal behaviors in several important ways, NSSI remains a strong predictor of a future suicide attempt. The primary goal of this project is to evaluate the treatment and acceptability of a brief intervention for NSSI that aims to reduce psychosocial impairment and NSSI behaviors in Veterans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
February 19, 2026
February 1, 2026
2.2 years
July 14, 2023
February 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility as measured by number of participants enrolled
All participants (N = 40) will need to be enrolled by the end of the second year of the study to consider the recruitment benchmark met.
2 years after study enrollment begins
Feasibility as measured rate of retention
Retention will be measured by the number of participants who complete at least six T-SIB treatment sessions. This benchmark will be considered meet if at least 2/3 of the 20 participants randomized to T-SIB complete at least 6 treatment sessions.
End of treatment, about nine weeks after beginning the study
Secondary Outcomes (1)
Number of participants who report satisfaction with the T-SIB treatment
End of treatment, about nine weeks after beginning the study
Study Arms (2)
T-SIB
EXPERIMENTALParticipants randomized to the Treatment for Self-Injurious Behaviors (T-SIB) condition will receive nine sessions of T-SIB.
Treatment As Usual
ACTIVE COMPARATORParticipants randomized to the TAU condition will be provided with referrals to both Durham VA and local community mental health resources and offered a consult for Durham VA mental health services.
Interventions
Participants randomized to the TAU condition will be provided with referrals to both Durham VA and local community mental health resources and offered a consult for Durham VA mental health services.
Treatment for Self-Injurious Behaviors (T-SIB) incorporates evidence-based approaches to replace NSSI with behaviors that improve psychosocial functioning.
Eligibility Criteria
You may qualify if:
- years of age or older
- Past service in the United States military
- Nonsuicidal self-injury engagement on 2 occasions in past 30 days
- Fluent in English
- Able to provide voluntary informed consent
You may not qualify if:
- Lifetime history of psychosis, mania, or hypomania
- Imminent risk for suicide/homicide warranting immediate intervention
- Unable/unwilling to complete study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tate F Halverson, PhD
Durham VA Medical Center, Durham, NC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2023
First Posted
August 1, 2023
Study Start
October 15, 2024
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share